| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.084 | 0.5 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.04 | 0.5 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |